Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Midvale, Utah Clinical Trials

A listing of Midvale, Utah clinical trials actively recruiting patient volunteers.

RESULTS

Found (10) clinical trials

A Study of Experimental Medication BMS-986235 in Healthy Subjects

This is a study of experimental medication BMS-986235 in healthy subjects.

Phase

3.2 miles

Learn More »

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

The RSV PED-011 study is indicated as a Phase 1 in the study design due to programming limitations. In fact, the study is considered a Phase 1/2 and is designed to evaluate the safety, reactogenicity and immunogenicity of the RSV candidate vaccine when administered to infants aged 6 and 7 ...

Phase

3.2 miles

Learn More »

A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

The study is comprised of two parts: an initial dose escalation phase utilizing a 3 + 3 design to determine maximum tolerated dose followed by a dose expansion cohort in approximately 40 additional subjects. Study participants will initially receive DSP-0337 orally for 28 days (one cycle of treatment). If clinical ...

Phase

3.54 miles

Learn More »

Hyperbaric Oxygen Neutrophil-oxidative Burst and Cytokines

The investigators are interested in studying the influence of hyperbaric oxygen on neutrophils (a kind of white blood cell) and cytokines (cell proteins). Hyperbaric oxygen can enhance the way the immune system works, but the investigators don't fully know how that happens. the investigators are doing this study to learn ...

Phase

3.97 miles

Learn More »

Evaluation of the Safety Tolerability and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease

This is a Phase 1b, open-label, dose-escalation, signal-finding, multi-center study. The study will evaluate the safety, tolerability, pharmacokinetics and short-term efficacy of MDGN-002 in adults with moderate to severe, active Crohn's disease who have previously failed anti-tumor necrosis factor alpha (anti-TNF) treatment.

Phase

6.44 miles

Learn More »

A Study of Seltorexant (JNJ-42847922) After Single-Dose Administration in Healthy Participants

The purpose of this study is to compare the rate and extent of absorption (relative bioavailability) of seltorexant Phase 3 test formulation(s) relative to a reference Phase 2b tablet formulation dosed 3 hours after evening meal (semi-fasted condition) and to assess the effect of a high-fat/high-calorie meal, timing of the ...

Phase

6.44 miles

Learn More »

A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD)

The main purpose of this study is to evaluate the safety and tolerability of LY3372993 in healthy participants and participants with AD. The study will also investigate how much LY3372993 gets into the bloodstream and test the effects of LY3372993 in participants with AD. The study has two parts: Part ...

Phase

6.44 miles

Learn More »

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

This is an open-label, Phase 1b, 3 Part (Part 1a, Part 1b, and Part 2), multi-center study. Part 1a utilizes a 3+3 design to evaluate pembrolizumab and INCB combinations in advanced solid tumors. Group A will evaluate a JAK inhibitor with JAK1 selectivity itacitinib (INCB039110) in combination with pembrolizumab (MK-3475) ...

Phase

6.95 miles

Learn More »

Safety and Efficacy Study of RP4010 in Patients With Relapsed or Refractory Lymphomas

Safety: Treatment-Emergent Adverse Events (AE); Treatment related AE, Serious Adverse Events (SAE) and Clinical significant AE; Dose Limiting Toxicities (DLT). Pharmacokinetics (PK): Peak Plasma Concentration (Cmax), Area under the plasma concentration versus time curve (AUC), Time of Maximum Concentration Observed (Tmax). Efficacy: Overall Response Rate (ORR), Progression Free Survival (PFS); ...

Phase

6.95 miles

Learn More »

Mechanisms of Skeletal Muscle Insulin Resistance in Older Adults

The investigator team will recruit younger and older (N=30; 18-35y and 60-85 yrs) male and female adults recruited in the Salt Lake City area. The investigator team will then schedule separate visits for Strength, Power and Physical Function and the separate visits for Lean Mass and OGTT measurements (see description ...

Phase

9.54 miles

Learn More »